ANDA 70119, held by Intl Medication. Bretylium Tosylate.
As of Nov 16, 2026, ANDA 70119 (Bretylium Tosylate), held by Intl Medication, was first approved by FDA on Mar 6, 1986, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 6, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Bretylium Tosylate50MG/ML · injectable;injection | Bretylium Tosylate | Discontinued |
| Jan 14, 1998 | Supplement 14Manufacturing | Approved | None posted |
| Sep 19, 1995 | Supplement 17Manufacturing | Approved | None posted |
| Nov 8, 1994 | Supplement 16Labeling | Approved | None posted |
| Jun 17, 1994 | Supplement 15Manufacturing | Approved | None posted |
| Oct 29, 1993 | Supplement 12Manufacturing | Approved | None posted |
| Sep 30, 1993 | Supplement 13Labeling | Approved | None posted |
| Jul 31, 1992 | Supplement 7Manufacturing | Approved | None posted |
| Jul 31, 1992 | Supplement 8Manufacturing | Approved | None posted |
| Feb 18, 1992 | Supplement 9Labeling | Approved | None posted |
| Apr 19, 1991 | Supplement 5Manufacturing | Approved | None posted |
| Apr 19, 1991 | Supplement 6Manufacturing | Approved | None posted |
| May 6, 1987 | Supplement 1Manufacturing | Approved | None posted |
| Mar 6, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters